Inosine pranobex

DB13156ApprovedSmall molecule

Inosine pranobex is a medication used to treat subacute sclerosing panencephalitis. Inosine pranobex (Isoprinosine or Methisoprinol) is a combination of inosine, acetamidobenzoic acid, and dimethylaminoisopropanol used as an antiviral drug.

Chemical structure of Inosine pranobex
Mechanism
Curator reviewed
Primary indication
Inosine pranobex is also indicated for mucocutaneous infections due to herpes simplex virus (type 1 and type II) and for treatment of genital warts as adjunctive therapy to podophyllin or carbon dioxide laser.Curator reviewed · 1 structured indication
Formula / weight
C52H78N10O17 · 1115.249 g/mol (avg)
First approval
Canada, 2012
Also known as
Inosine acedobene dimepranol · Inosiplex · Isoprinosine · Methisoprinol
Code names
NP-113 · NPT-10381
Brand names
  • Imunovir

Resolves to

Clinical / RWD
Structure
InChIKeyYLDCUKJMEKGGFI-KSIULYHRSA-NSMILESC[C@@H](O)CN(C)C.C[C@@H](O)CN(C)C.C[C@@H](O)CN(C)C.CC(=O)NC1=CC=C(C=C1)C(O)=O.CC(=O)NC1=CC=C(C=C1)C(O)=O.CC(=O)NC1=CC=C(C=C1)C(O)=O.OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CNC2=O

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
747Drug interactionsStructured to mechanism, not free text
Sign in
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
80Marketed productsAcross 7 countries and 39 labellers
Sign in
1ATC codeIncluding every combination product, plus 17 drug categories
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Inosine pranobex, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account